Ben Yong bought BBOT
March 10, 2026 · Form 4 insider transaction
Ben Yong bought 210,000 shares of BridgeBio Oncology Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
210,000
Price
$0.00
Total value
N/A
InsiderBen Yong
RoleOfficer, Director
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateMarch 10, 2026
Filing dateMarch 12, 2026
Shares owned after210,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
1/48th of the shares subject to such option vest and become exercisable in substantially equal monthly installments on each monthly anniversary of January 1, 2026, subject to the Reporting Person's continuous service to the Issuer on each such date.